Tsai et al. (2012) identified a potential therapeutic approach for melanoma by demonstrating that inhibition of the PI3K/AKT signaling pathway with a specific in-hibitor can suppress c-Myc-induced effects and significantly enhance cell killing medi-ated by ADI. Here, AKT1 is linked to melanoma.